Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB00619Imatinib1Terminated1
DB08901PonatinibNot AvailableApproved for Marketing1